BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7342082)

  • 1. Factors affecting prostaglandin endoperoxide transformation: antibodies against PGH2.
    Fitzpatrick FA; Pike JE
    Prog Lipid Res; 1981; 20():179-82. PubMed ID: 7342082
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues.
    Morinelli TA; Niewiarowski S; Kornecki E; Figures WR; Wachtfogel Y; Colman RW
    Blood; 1983 Jan; 61(1):41-9. PubMed ID: 6293626
    [No Abstract]   [Full Text] [Related]  

  • 3. Partial agonism of prostaglandin H2 analogs and 11-deoxy-prostaglandin F2 alpha to thromboxane-sensitive preparations.
    Jones RL; Wilson NH
    Adv Prostaglandin Thromboxane Res; 1980; 6():467-75. PubMed ID: 7386280
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of collagen-induced platelet activation by 5'-p-fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides.
    Colman RW; Figures WR; Scearce LM; Strimpler AM; Zhou FX; Rao AK
    Blood; 1986 Aug; 68(2):565-70. PubMed ID: 3730618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin H2 directly lowers human platelet cAMP levels.
    Rybicki JP; Le Breton GC
    Thromb Res; 1983 Jun; 30(5):407-14. PubMed ID: 6310815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovine maternal and fetal circulatory responses to an endoperoxide analog.
    Schwartz DB; Phernetton TM; Stock MK; Rankin JH
    Proc Soc Exp Biol Med; 1982 Oct; 171(1):46-9. PubMed ID: 7145937
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB; Patscheke H
    Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of 1-iodo-3-aminomethyl-5,6,7,8-tetrahydro-2-naphthol (ONO-3122) and prostaglandin H2 on vasopressin-induced osmotic water flow in toad bladder.
    Marumo F
    Experientia; 1982 Jul; 38(7):828-9. PubMed ID: 6809486
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of prostaglandin H2 on perinatal pulmonary circulation.
    Tod ML; Cassin S; McNamara DB; Kadowitz PJ
    Pediatr Res; 1986 Jun; 20(6):565-9. PubMed ID: 3714368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PGH2.
    Tilden SJ; Underwood DC; Cowen KH; Wegmann MJ; Graybar GB; Hyman AL; McNamara DB; Kadowitz PJ
    J Appl Physiol (1985); 1987 May; 62(5):2066-74. PubMed ID: 2954941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of lymphatic contractility by arachidonate metabolites.
    Johnston MG; Gordon JL
    Nature; 1981 Sep; 293(5830):294-7. PubMed ID: 7196995
    [No Abstract]   [Full Text] [Related]  

  • 14. Potentiation of itch and flare responses in human skin by prostaglandins E2 and H2 and a prostaglandin endoperoxide analog.
    Hägermark O; Strandberg K; Hamberg M
    J Invest Dermatol; 1977 Dec; 69(6):527-30. PubMed ID: 925375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel arachidonic acid metabolites formed by prostaglandin H synthase.
    Hecker M; Ullrich V; Fischer C; Meese CO
    Eur J Biochem; 1987 Nov; 169(1):113-23. PubMed ID: 3119336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of vascular resistance with endocrine pancreas secretion: the effects of epoxymethano analogs of PGH2.
    Akpan JO; Hurley MC; Pek S; Lands WE
    Prostaglandins Med; 1981 Dec; 7(6):473-81. PubMed ID: 7034020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2.
    Gorman RR; Fitzpatrick FA; Miller OV
    Biochem Biophys Res Commun; 1977 Nov; 79(1):305-13. PubMed ID: 200243
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthetic studies on Prostanoids. XX. Synthesis of stable (+/-)-prostaglandin H1 analogs.
    Sakai K; Inoue K; Amemiya S; Morita A; Kojima K
    Chem Pharm Bull (Tokyo); 1980 Jun; 28(6):1814-9. PubMed ID: 7408058
    [No Abstract]   [Full Text] [Related]  

  • 19. Contractile responses of intrapulmonary vessels from three species to arachidonic acid and an epoxymethano analog of PGH2.
    Gruetter CA; McNamara DB; Hyman AL; Kadowitz PJ
    Can J Physiol Pharmacol; 1978 Apr; 56(2):206-15. PubMed ID: 638873
    [No Abstract]   [Full Text] [Related]  

  • 20. Desensitisation of human platelets against stimulation by thromboxane mimics--reduction in receptor capacity and loss of functional response.
    Thierauch KH; Gabriel D; Prior G; Schillinger E
    Biomed Biochim Acta; 1988; 47(10-11):S75-8. PubMed ID: 2470362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.